Global X HealthTech ETFHEAL

Global X launched HEAL on April 16, 2023, billing it as a vehicle to capture “companies poised to benefit from the digital transformation of healthcare.” The fund’s prospectus, filed with the SEC, defines its universe as businesses engaged in developing or applying healthcare technology, including telehealth, AI diagnostics, and digital therapeutics. In practice, that universe is dominated by large-cap healthcare services and managed-care incumbents whose business models predate the smartphone. (source: SEC EDGAR fund search for HEAL, https://www.sec.gov/edgar/search/#/q=HEAL)

The ETF’s top five holdings-UnitedHealth Group, Thermo Fisher Scientific, Intuitive Surgical, Veeva Systems, and Teladoc-account for 39% of the portfolio, a concentration level that would make even a concentrated equity fund blush. UnitedHealth alone carries a 12.3% weight, a figure that underscores how far HEAL is from a pure-play health-tech exposure. The issuer’s fund centre page shows the index is rebalanced quarterly and reconstituted annually, using a rules-based methodology that prioritises liquidity and market cap over thematic purity. (source: Global X ETFs official fund centre, https://www.globalxetfs.com/funds/heal)

Fees are where the wrapper’s promise meets the portfolio’s reality. HEAL charges 0.68% per year, a figure that places it above the category median for large-cap healthcare ETFs and closer to actively managed funds than to plain-vanilla index peers. The fund’s AUM stands at $124 million as of July 25, 2026, down from its 2024 peak of $158 million, reflecting both market drift and the thin liquidity profile that keeps most volume on the primary market. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)

The ETF’s tracking method is designed to mirror the Indxx Global Health Innovation Index, a rules-based benchmark that screens for companies involved in the research, development, or application of healthcare technology. The index methodology, outlined on Global X’s product page, filters for market cap, float, and liquidity, effectively excluding many early-stage innovators that don’t clear the liquidity hurdle. The result is a portfolio that looks less like a venture-capital thesis and more like a committee-approved shopping list of large-cap healthcare stocks. (source: Global X ETFs official fund centre, https://www.globalxetfs.com/funds/heal)

For context, Global X’s Artificial Intelligence & Technology ETF (AIQ) uses a similar wrapper design-0.68% fee, quarterly rebalancing-but its index, the Indxx Artificial Intelligence & Big Data Index, is built around companies with measurable exposure to AI infrastructure and applications across sectors, not just healthcare. AIQ’s AUM of $480 million and average daily volume of 110,000 shares dwarf HEAL’s numbers, underscoring how thematic clarity and liquidity can shape investor appetite even when the fee is identical. (source: Artificial Intelligence & Technology ETF (AIQ), https://www.globalxetfs.com/funds/aiq)

On Nasdaq, HEAL’s average daily volume is roughly 18,000 shares, a figure that places it in the bottom decile of ETF liquidity rankings. The thin secondary-market activity means spreads can widen during volatile sessions, adding hidden friction to a fee that’s already above the category median. The fund’s listing page shows the bid-ask spread has spiked to 0.40% on several days this quarter, a level that can erase weeks of relative performance for buy-and-hold investors. (source: Nasdaq HEAL listing activity, https://www.nasdaq.com/market-activity/etf/heal)

Global X’s broader lineup spans disruptive tech, equity income, and commodities, but the company’s press centre and fund pages offer no recent updates specific to HEAL’s holdings, flows, or performance. The latest “In The News” post from Global X covers the launch of an Ethereum covered-call ETF targeting weekly distributions, a product that sits in a different risk bucket altogether. For HEAL, the silence from the issuer’s news rail is louder than any press release. (source: In The News, https://www.globalxetfs.com/news)